MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-13-2026
Stereotaxis Operating Cash Flow 2011-2026 | STXS
Annual Operating Cash Flow Stereotaxis
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13.7 M | -8.5 M | -9.14 M | -8.42 M | -2.95 M | -3.51 M | -4.62 M | -2.55 M | -4.67 M | - | - | - | - | -12.1 M | -31.6 M | -18.9 M | -22.3 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.55 M | -31.6 M | -11 M |
Quarterly Operating Cash Flow Stereotaxis
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.44 M | - | - | -1.78 M | - | - | -2.35 M | - | - | -2.8 M | - | -5.86 M | -3.33 M | -2.19 M | - | -1.73 M | -271 K | -305 K | - | -3.82 M | -3.34 M | -2.17 M | - | -2.7 M | -2.3 M | -1.78 M | - | -1.77 M | -1.53 M | -2.02 M | - | -3.87 M | -3.38 M | -2.67 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.15 M | - | - | -8.41 M | -4.22 M | - | -20 M | -14.8 M | -10 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -271 K | -20 M | -4.07 M |
Operating Cash Flow of other stocks in the Medical instruments industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
20 K | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
796 M | $ 61.75 | 0.49 % | $ 12.3 B | USA |
 |
ICU Medical
ICUI
|
180 M | $ 129.31 | 4.57 % | $ 3.19 B | USA |
 |
Alcon
ALC
|
1.34 B | $ 67.28 | 1.48 % | $ 40.4 B |  Schweiz |
 |
Intuitive Surgical
ISRG
|
3.03 B | $ 449.03 | 1.69 % | $ 160 B | USA |
 |
iRhythm Technologies
IRTC
|
80.9 M | $ 117.0 | 2.78 % | $ 3.74 B | USA |
 |
Repro Med Systems
KRMD
|
462 K | $ 4.0 | 1.01 % | $ 185 M | USA |
 |
LeMaitre Vascular
LMAT
|
81.3 M | $ 101.43 | 0.1 % | $ 2.3 B | USA |
 |
Masimo Corporation
MASI
|
196 M | $ 178.79 | -0.01 % | $ 9.53 B | USA |
 |
Milestone Scientific
MLSS
|
-2.92 M | $ 0.4 | 14.99 % | $ 32.8 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
-11.8 M | - | - | $ 28.6 M | USA |
 |
electroCore
ECOR
|
-8.19 M | $ 6.13 | 3.81 % | $ 52 K | USA |
 |
Envista Holdings Corporation
NVST
|
276 M | $ 23.77 | 3.15 % | $ 3.99 B | USA |
 |
Haemonetics Corporation
HAE
|
182 M | $ 59.56 | 4.79 % | $ 3 B | USA |
 |
STERIS plc
STE
|
1.15 B | $ 215.97 | 0.67 % | $ 21.3 B | USA |
 |
Isoray
ISR
|
-82.5 M | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
-57.8 M | $ 143.82 | 2.71 % | $ 6.97 B | USA |
 |
STAAR Surgical Company
STAA
|
-34.2 M | $ 33.05 | 1.38 % | $ 1.64 B | USA |
 |
InfuSystem Holdings
INFU
|
24.4 M | $ 10.16 | 5.07 % | $ 210 M | USA |
 |
Microbot Medical
MBOT
|
-13 M | $ 1.74 | 0.58 % | $ 79.7 M |  Israel |
 |
Utah Medical Products
UTMD
|
14.7 M | $ 64.17 | 0.27 % | $ 208 M | USA |
 |
Merit Medical Systems
MMSI
|
297 M | $ 64.49 | 1.13 % | $ 3.82 B | USA |
 |
West Pharmaceutical Services
WST
|
755 M | $ 305.5 | 0.55 % | $ 22.1 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
235 M | $ 9.84 | 1.03 % | $ 1.96 B | USA |
 |
Pulse Biosciences
PLSE
|
-54.1 M | $ 26.09 | 4.57 % | $ 1.76 B | USA |
 |
Retractable Technologies
RVP
|
-7.06 M | $ 0.66 | -2.35 % | $ 19.8 M | USA |
 |
Pro-Dex
PDEX
|
-1.68 M | $ 63.47 | 4.43 % | $ 209 M | USA |
 |
Predictive Oncology
POAI
|
-13.2 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
20.1 M | $ 24.0 | 4.12 % | $ 1.15 B | USA |
 |
Baxter International
BAX
|
845 M | $ 18.77 | 2.37 % | $ 9.63 B | USA |
 |
ResMed
RMD
|
351 M | $ 209.86 | 0.98 % | $ 30.7 B | USA |
 |
AtriCure
ATRC
|
57.3 M | $ 29.0 | 0.69 % | $ 1.38 B | USA |
 |
Harvard Bioscience
HBIO
|
6.73 M | $ 5.4 | 7.78 % | $ 240 M | USA |
 |
NeuroMetrix
NURO
|
-7.13 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
-10.1 M | $ 11.81 | 3.23 % | $ 482 M | USA |
 |
Becton, Dickinson and Company
BDX
|
3.33 B | $ 146.95 | 0.02 % | $ 42.3 B | USA |
 |
Nephros
NEPH
|
1.64 M | $ 3.57 | -1.79 % | $ 37.9 M | USA |
 |
OraSure Technologies
OSUR
|
-49 M | $ 3.07 | -0.32 % | $ 226 M | USA |
 |
Repligen Corporation
RGEN
|
117 M | $ 111.74 | 2.97 % | $ 6.28 M | USA |